91 related articles for article (PubMed ID: 2159727)
21. Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs.
Burke SE; Antonaccio MJ; Lefer AM
Basic Res Cardiol; 1982; 77(4):411-22. PubMed ID: 6890805
[TBL] [Abstract][Full Text] [Related]
22. Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.
Pieper GM; Farber NE; Gross GJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):13-22. PubMed ID: 3054935
[TBL] [Abstract][Full Text] [Related]
23. Coronary artery reperfusion: effects of occlusion duration on reactive hyperemia responses.
Bloor CM; White FC
Basic Res Cardiol; 1975; 70(2):148-58. PubMed ID: 1079724
[TBL] [Abstract][Full Text] [Related]
24. Modulation of human neutrophil superoxide production by selective thromboxane synthetase inhibitor U63,557A.
Mehta JL; Lawson D; Mehta P
Life Sci; 1988; 43(11):923-8. PubMed ID: 2842563
[TBL] [Abstract][Full Text] [Related]
25. Thromboxane is not responsible for the high pulmonary vascular resistance in fetal lambs.
Clozel M; Clyman RI; Soifer SJ; Heymann MA
Pediatr Res; 1985 Dec; 19(12):1254-7. PubMed ID: 4080442
[TBL] [Abstract][Full Text] [Related]
26. Effect of a critical coronary stenosis on myocardial neutrophil accumulation during ischemia and early reperfusion in dogs.
Richard VJ; Brooks SE; Jennings RB; Reimer KA
Circulation; 1989 Dec; 80(6):1805-15. PubMed ID: 2598439
[TBL] [Abstract][Full Text] [Related]
27. Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.
Datar S; McCauley FA; Wilson TW
Prostaglandins; 1987 Feb; 33(2):275-85. PubMed ID: 3296006
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction.
de Gusmão FM; Becker C; Carvalho MH; Barros LF
Int J Cardiol; 2005 Apr; 100(3):363-70. PubMed ID: 15837077
[TBL] [Abstract][Full Text] [Related]
29. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogs.
Grover GJ
Proc Soc Exp Biol Med; 1989 Oct; 192(1):56-60. PubMed ID: 2529546
[TBL] [Abstract][Full Text] [Related]
31. Studies on prolonged acute regional ischemia. IV. Aggressive surgical treatment for intractable ventricular fibrillation after acute myocardial infarction.
Beyersdorf F; Acar C; Buckberg GD; Partington MT; Okamoto F; Allen BS; Bugyi HI; Young HH
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):557-66. PubMed ID: 2796363
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of reperfusion hyperemia with myocardial contrast echocardiography.
Armstrong WF; Gage SW
J Am Soc Echocardiogr; 1988; 1(5):322-32. PubMed ID: 2978809
[TBL] [Abstract][Full Text] [Related]
33. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.
Parratt JR; Coker SJ; Wainwright CL
J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537
[TBL] [Abstract][Full Text] [Related]
34. Reduction of infarct size and infiltration of polymorphonuclear leukocytes by a thromboxane synthetase inhibitor. Studies in a rabbit ischemic heart model.
Ito T; Asai F; Ushiyama S; Matsuda K; Oshima T
Arzneimittelforschung; 1990 Jan; 40(1):23-7. PubMed ID: 1692704
[TBL] [Abstract][Full Text] [Related]
35. Coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion in anaesthetised dogs.
Tanabe M; Terashita ZI; Fujiwara S; Shimamoto N; Goto N; Nishikawa K; Hirata M
Cardiovasc Res; 1982 Feb; 16(2):99-106. PubMed ID: 7074670
[TBL] [Abstract][Full Text] [Related]
36. Myocardial prostacyclin and thromboxane A2 synthetase activities during ischemia and reperfusion in isolated rabbit heart.
Chahine R; Chanh AP; Lasserre B; Dossou-Gbete V
Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):261-6. PubMed ID: 1946554
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
Grover GJ; Fulmor IE
J Pharmacol Exp Ther; 1988 Nov; 247(2):445-52. PubMed ID: 3183946
[TBL] [Abstract][Full Text] [Related]
38. [Coronary flow reserve during myocardial reperfusion, after 15 minutes of ischemia].
Jorge PA; Curti HH; Metze K
Arq Bras Cardiol; 1990 Mar; 54(3):193-7. PubMed ID: 2288505
[TBL] [Abstract][Full Text] [Related]
39. Increased prostacyclin and adverse hemodynamic responses to protamine sulfate in an experimental canine model.
Wakefield TW; Wrobleski SK; Wirthlin DJ; Wang TW; Stanley JC
J Surg Res; 1991 May; 50(5):449-56. PubMed ID: 2038184
[TBL] [Abstract][Full Text] [Related]
40. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion.
Kofsky ER; Julia PL; Buckberg GD; Quillen JE; Acar C
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):350-9. PubMed ID: 1992246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
